McKesson Corporation (LON:0JZU)

Market Cap	86.02B +39.8%
Revenue (ttm)	295.68B +15.5%
Net Income	3.22B +53.6%
EPS	25.81 +59.2%
Shares Out	n/a
PE Ratio	26.68
Forward PE	22.07
Dividend	2.32 (0.25%)
Ex-Dividend Date	Dec 1, 2025

Volume	691
Average Volume	658
Open	939.00
Previous Close	944.50
Day's Range	930.00 - 947.23
52-Week Range	595.01 - 971.93
Beta	0.41
RSI	60.45
Earnings Date	Feb 4, 2026

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1833
• Employees: 44,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0JZU

Financial Performance

In fiscal year 2025, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.

Financial numbers in USD